The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combining the albumin-bilirubin (ALBI) score and ECOG performance status for enhanced prognostication in advanced biliary tract cancer treated with durvalumab-based immunochemotherapy.
 
Chi-Chen Lan
No Relationships to Disclose
 
Wen-Kuan Huang
No Relationships to Disclose
 
Chun-Feng Wu
No Relationships to Disclose
 
Tsung-Han Wu
No Relationships to Disclose
 
Chiao-En Wu
No Relationships to Disclose
 
Jen-Shi Chen
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; MSD Oncology; Ono Pharmaceutical; Taiho Oncology; Taivex Therapeutics Corporation; TTY Biopharm
(OPTIONAL) Uncompensated Relationships - Taiwan Oncology Society
 
Chia-Hsun Hsieh
No Relationships to Disclose
 
Yu-Shin Hung
No Relationships to Disclose
 
Wen-Chi Chou
No Relationships to Disclose